Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeiger Counter Regulatory News (GCL)

Share Price Information for Geiger Counter (GCL)

Share Price is delayed by 15 minutes
Get Live Data
72.80    2.20 (3.13%)
Bid:
71.00
Ask:
74.60
Spread: 3.60 (5.07%)
Market Cap: £91.33m
GCL Live PriceLast checked at - London Stock Exchange

Intraday Geiger Counter Share Chart

Net Asset Value(s)

14 Apr 2026 07:52

RNS Number : 3601A
Geiger Counter Ltd
14 April 2026
 

Geiger Counter Limited

(the "Company")

Net Asset Value

 

Geiger Counter Limited (LSE: GCL) announces that as at the close of business on 10 April 2026 its unaudited net asset value ("NAV") per ordinary share ("Share") was as follows:

 

Date of announcement

13 April 2026

Date of NAV

10 April 2026

NAV per share - undiluted

88.24 pence per share

NAV per share - fully diluted

79.74 pence per share

No of voting shares in issue

104,836,041

Subscription Exercise Price

37.20 pence per share

Next Subscription Date

1 May 2026

 

*Notes relating to the NAV dilution

The dilution is in relation to the effect of the Company's embedded annual Subscription Right. Shareholders should note that the dilution refers to the NAV per share dilution, not to the dilution of Shareholders' holdings in the Company. All Shareholders have the right to take up their subscription rights on 1 May in each year and those who do take them up in full don't have their percentage holding in the Company diluted. For those investors who don't take up their subscription rights, the Company endeavours to place in the market the shares that they were entitled to subscribe for, and then return the net sale proceeds to those investors as a way to deliver to them as much as possible of the value of their subscription rights, therefore reducing the dilution effect of not subscribing.

 

About the annual Subscription Right

Shareholders have the right to subscribe for one new Ordinary Share for every five Ordinary Shares held in the Company on the Record Date, as outlined in the circular published on 31 March 2021. The exercise price is equal to the undiluted NAV per share on 30 April one year prior. The aim of the programme is to enable to Company to grow through share issuance and it is subject to shareholder review at the annual general meeting ("AGM") in 2026 and at every fifth subsequent AGM thereafter.

 

Enquiries

Manulife | CQS Investment Management

Craig Cleland +44 (0) 20 7201 5368

 

Cavendish Capital Markets Limited

Daniel Balabanoff / Pauline Tribe (Sales +44 (0) 20 7720 0500)

Tunga Chigovanyika (Corporate Finance Director +44 (0) 20 7397 1915)

 

Summit Fund Services Jersey Limited

Christopher Foulds +44 (0) 1534 825 259

 

About Geiger Counter Limited

 

Geiger Counter Limited is a closed-ended investment company incorporated with limited liability in Jersey. The Company's investment objective is to provide attractive returns to Shareholders principally in form of capital growth, through investment in companies involved in the exploration, development and production or uranium to supply the nuclear power industry.

 

For the latest factsheet and other information, click here.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVGLGDSGUBDGLS
Date   Source Headline
11th Aug 20253:16 pmRNSNet Asset Value(s)
11th Aug 20259:30 amRNSShare Buyback
8th Aug 20255:16 pmRNSTotal Voting Rights - Replacement
8th Aug 20255:10 pmRNSNet Asset Value(s)
8th Aug 20254:48 pmRNSShare Buyback
8th Aug 20257:00 amRNSResults of General Meeting
7th Aug 20253:04 pmRNSNet Asset Value(s)
7th Aug 20259:58 amRNSTotal Voting Rights
7th Aug 20259:54 amRNSShare Buyback
6th Aug 20251:17 pmRNSNet Asset Value(s)
5th Aug 20253:13 pmRNSNet Asset Value(s)
4th Aug 20255:08 pmRNSNet Asset Value(s)
1st Aug 20255:21 pmRNSNet Asset Value(s)
1st Aug 202511:52 amRNSShare Buyback
31st Jul 20252:35 pmRNSNet Asset Value(s)
30th Jul 20254:36 pmRNSNet Asset Value(s)
29th Jul 20253:54 pmRNSNet Asset Value(s)
28th Jul 20253:11 pmRNSNet Asset Value(s)
28th Jul 20258:33 amRNSNet Asset Value(s)
24th Jul 20254:32 pmRNSNet Asset Value(s)
24th Jul 20251:49 pmRNSShare Buyback
23rd Jul 20255:13 pmRNSMonthly Factsheet- June 2025
23rd Jul 202512:59 pmRNSNet Asset Value(s)
23rd Jul 202510:16 amRNSShare Buyback
22nd Jul 20253:01 pmRNSNet Asset Value(s)
22nd Jul 20258:15 amRNSShare Buyback
21st Jul 20253:57 pmRNSNet Asset Value(s)
21st Jul 20257:00 amRNSNotice of GM - 7 August 2025
18th Jul 20253:05 pmRNSNet Asset Value(s)
17th Jul 202512:47 pmRNSNet Asset Value(s)
17th Jul 20259:54 amRNSShare Buyback
16th Jul 20253:54 pmRNSNet Asset Value(s)
16th Jul 202510:13 amRNSShare Buyback
15th Jul 20252:52 pmRNSNet Asset Value(s)
14th Jul 20252:48 pmRNSNet Asset Value(s)
11th Jul 20253:22 pmRNSNet Asset Value(s)
10th Jul 20253:00 pmRNSNet Asset Value(s)
10th Jul 20252:48 pmRNS-RAnnual Overview from QuotedData
9th Jul 20254:23 pmRNSNet Asset Value(s)
9th Jul 202510:20 amRNSShare Buyback
8th Jul 20251:12 pmRNSNet Asset Value(s)
8th Jul 20259:57 amRNSShare Buyback
7th Jul 20253:48 pmRNSNet Asset Value(s)
7th Jul 20259:17 amRNSShare Buyback
4th Jul 202512:47 pmRNSNet Asset Value(s)
4th Jul 20258:58 amRNSShare Buyback
3rd Jul 20253:22 pmRNSNet Asset Value(s)
2nd Jul 20253:24 pmRNSNet Asset Value(s)
2nd Jul 20259:27 amRNSShare Buyback
1st Jul 20253:59 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.